XCT790

XCT790 is an agonist of Estrogen/Progesterone Receptors used in studies of Apoptosis and Hormone Signaling. In practice, this places the compound in experiments that measure caspase-associated cell-death signaling and survival decisions and ligand-dependent transcriptional programs and endocrine regulation in angiogenesis, apoptosis, and cancer models.

By activating Estrogen/Progesterone Receptors, XCT790 can be used to examine caspase-associated cell-death signaling and survival decisions and ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In angiogenesis, apoptosis, and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Estrogen/Progesterone Receptors
• Pathway perturbation studies connected to Apoptosis and Hormone Signaling
• Agonist-response and downstream signaling studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, XCT790 is appropriate when a defined chemical perturbant is needed to connect Estrogen/Progesterone Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in angiogenesis, apoptosis, and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.